Skip to main content
Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.27
+0.05 (0.96%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Evolus Revenue

In the year 2025, Evolus had annual revenue of $297.18M with 11.61% growth. Evolus had revenue of $90.30M in the quarter ending December 31, 2025, with 14.38% growth.

Revenue (ttm)
$297.18M
Revenue Growth
+11.61%
P/S Ratio
1.15
Revenue / Employee
$889,749
Employees
334
Market Cap
342.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025297.18M30.90M11.61%
Dec 31, 2024266.27M64.19M31.76%
Dec 31, 2023202.09M53.47M35.98%
Dec 31, 2022148.62M48.94M49.10%
Dec 31, 202199.67M43.13M76.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 742.90M
Organogenesis Holdings 564.17M
Esperion Therapeutics 403.14M
Aurora Cannabis 272.13M
Akebia Therapeutics 236.20M
Organigram Global 204.21M
Canopy Growth 203.04M
Kamada 180.46M
Revenue Rankings

EOLS News

More News